MOLECULAR DIAGNOSTIC SCREENING ASSAY

• US 20130210659A1
• Filed: 02/11/2013
• Published: 08/15/2013
• Est. Priority Date: 02/10/2012
• Status: Abandoned Application

• Current Assignee: Andrew Watson, Darren Roy Link, Jeffrey Charles Olson, Michael Samuels
• Original Assignee: Andrew Watson, Darren Roy Link, Jeffrey Charles Olson, Michael Samuels
• Inventors: Watson, Andrew, Link, Darren Roy, Olson, Jeffrey Charles, Samuels, Michael
• Application Number:
  US13/764,459
• Publication Number:
  US 20130210659A1
• Time in Patent Office: Days
• US Class Current: 506/9
• CPC Class Codes: C12N 15/1072 Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 1/6844 Nucleic acid amplification reactions
• CPC Class Codes: C12Q 1/6883 for diseases caused by alterations of genetic material
• CPC Class Codes: C12Q 1/6886 for cancer immunoassay for cancer G01N33/574
• CPC Class Codes: C12Q 2521/319 Exonuclease
• CPC Class Codes: C12Q 2521/501 Ligase
• CPC Class Codes: C12Q 2525/155 incorporating/generating a new priming site
• CPC Class Codes: C12Q 2525/161 incorporating target specific and non-target specific sites
• CPC Class Codes: C12Q 2545/101 with an internal standard/control
• CPC Class Codes: C12Q 2563/159 Microreactors, e.g. emulsion PCR or sequencing, droplet PCR, microcapsules, i.e. non-liquid containers with a range of different permeability's for different reaction components
• CPC Class Codes: C12Q 2563/179 the label being a nucleic acid
• CPC Class Codes: C12Q 2565/629 being a microfluidic device
• CPC Class Codes: C12Q 2600/156 Polymorphic or mutational markers

Abstract

The invention generally relates to method for screening for a condition in a subject. In certain embodiments, methods of the invention involve obtaining a pool of nucleic acids from a sample, incubating the nucleic acids with first and second sets of binders, in which the first set binds uniquely to different regions of a target nucleic acid in the pool, the second set binds uniquely to different regions of a reference nucleic acid in the pool, and the first and second sets include different detectable labels, removing unbound binders, detecting the labels, and screening for a condition based upon results of the detecting step.

Claims

1. A method for disease screening, the method comprising:

obtaining nucleic acid from a sample;

incubating the nucleic acid with first and second sets of binders, wherein members of the first set bind to different regions of a target nucleic acid, members of the second set bind to different regions of a reference nucleic acid, and members of the first set comprise a detectable label that is different than members of the second set;

removing unbound binders;

detecting the labels; and

identifying a positive screen based upon differential presence of label between said first and second sets.

2. The method according to claim 1, wherein the detectable labels are barcode sequences and detecting comprises sequencing the barcodes.

3. The method according to claim 2, wherein said identifying step comprises

counting a number of labels from the first set;

counting a number of labels from the second set; and

determining whether a statistical difference exists between the number of barcodes from the first set and the number of barcodes from the second set.

4. The method according to claim 1, wherein after the removing step, the method further comprises:

compartmentalizing bound binders of the first and second set into compartmentalized portions, the compartmentalized portions comprising, on average, either the first set of binders or the second set of binders; and

amplifying binders in the compartmentalized portions.

5. The method according to claim 4, wherein the binders of the first set comprise the same universal primer site and the binders of the second set comprise the same universal primer site, wherein the primer sites of the first and second binders are different.

6. The method according to claim 5, wherein the compartmentalized portions further comprise universal primers that bind the universal priming sites of the binders of the first set and universal primers that bind the universal priming sites of the binders of the second set.

7. The method according to claim 6, wherein amplifying is the polymerase chain reaction.

8. The method according to claim 6, wherein the compartmentalized portions further comprise probes that bind the detectable label of the first set of binders and probes that bind the detectable label of the second set of binders.

9. The method according to claim 8, wherein detecting comprises optically detecting the bound probes.

10. The method according to claim 9, wherein determining comprises:

counting a number of compartmentalized portions comprising the first detectable label;

counting a number of compartmentalized portions comprising the second detectable label; and

determining whether a statistical difference exists between the number of compartmentalized portions comprising the first detectable label and the number of compartmentalized portions comprising the second detectable label.

11. The method according to claim 4, wherein the compartmentalized portions are droplets and compartmentalizing comprises forming the droplets.

12. The method according to claim 11, wherein the droplets are aqueous droplets in an immiscible carrier fluid.

13. The method according to claim 12, wherein the immiscible carrier fluid is oil.

14. The method according to claim 13, wherein the oil comprises a surfactant.

15. The method according to claim 14, wherein the surfactant is a fluorosurfactant.

16. The method according to claim 13, wherein the oil is a fluorinated oil.

17. The method according to claim 1, wherein the condition is fetal aneuploidy.

18. The method according to claim 17, wherein the fetal aneuploidy is trisomy 21 (Down syndrome).

19. The method according to claim 18, wherein the sample is a maternal sample that comprises fetal cell-free circulating nucleic acid.

20. The method according to claim 19, wherein the target nucleic acid is nucleic acid of chromosome 21 and the first set of binders binds to the nucleic acid of chromosome 21 in the pool, and the second set of binders binds nucleic acid of a reference chromosome in the pool.

21. The method according to claim 20, wherein the detectable labels are barcode sequences and detecting comprises sequencing the barcodes.

22. The method according to claim 21, wherein determining comprises:

counting a number of barcodes from the first set;

counting a number of barcodes from the second set; and

determining whether a statistical difference exists between the number of barcodes from the first set and the number of barcodes from the second set.

23. The method according to claim 20, wherein after the removing step, the method further comprises:

compartmentalizing bound binders of the first and second set into compartmentalized portions, the compartmentalized portions comprising, on average, either the first set of binders or the second set of binders; and

amplifying binders in the compartmentalized portions.

24. The method according to claim 23, wherein the binders of the first set comprise the same universal primer site and the binders of the second set comprise the same universal primer site, wherein the primer sites of the first and second binders are different.

25. The method according to claim 24, wherein the compartmentalized portions further comprise universal primers that bind the universal priming sites of the binders of the first set and universal primers that bind the universal priming sites of the binders of the second set.

26. The method according to claim 25, wherein amplifying is the polymerase chain reaction.

27. The method according to claim 26, wherein the compartmentalized portions further comprise probes that bind the detectable label of the first set of binders and probes that bind the detectable label of the second set of binders.

28. The method according to claim 27, wherein detecting comprises optically detecting the bound probes.

29. The method according to claim 28, wherein determining comprises:

counting a number of compartmentalized portions comprising the first detectable label;

counting a number of compartmentalized portions comprising the second detectable label; and

determining whether a statistical difference exists between the number of compartmentalized portions comprising the first detectable label and the number of compartmentalized portions comprising the second detectable label.

30. The method according to claim 1, wherein the condition is cancer.

31. The method according to claim 30, wherein the first set of binders binds genomic regions of the nucleic acids associated with known mutations involved in different cancers and the second set of binders binds genomic regions of the nucleic acids that are not mutated.

32. The method according to claim 31, wherein the detectable labels are barcode sequences and detecting comprises sequencing the barcodes.

33. The method according to claim 32, wherein determining comprises:

counting a number of barcodes from the first set;

counting a number of barcodes from the second set; and

determining whether a statistical difference exists between the number of barcodes from the first set and the number of barcodes from the second set.

34. The method according to claim 31, wherein after the removing step, the method further comprises:

compartmentalizing bound binders of the first and second set into compartmentalized portions, the compartmentalized portions comprising, on average, either the first set of binders or the second set of binders; and

amplifying binders in the compartmentalized portions.

35. The method according to claim 34, wherein the binders of the first set comprise the same universal primer site and the binders of the second set comprise the same universal primer site, wherein the primer sites of the first and second binders are different.

36. The method according to claim 35, wherein the compartmentalized portions further comprise universal primers that bind the universal priming sites of the binders of the first set and universal primers that bind the universal priming sites of the binders of the second set.

37. The method according to claim 36, wherein amplifying is the polymerase chain reaction.

38. The method according to claim 37, wherein the compartmentalized portions further comprise probes that bind the detectable label of the first set of binders and probes that bind the detectable label of the second set of binders.

39. The method according to claim 38, wherein detecting comprises optically detecting the bound probes.

40. The method according to claim 39, wherein determining comprises:

counting a number of compartmentalized portions comprising the first detectable label;

counting a number of compartmentalized portions comprising the second detectable label; and

determining whether a statistical difference exists between the number of compartmentalized portions comprising the first detectable label and the number of compartmentalized portions comprising the second detectable label.

49. The method according to claim 23, wherein the compartmentalized portions are droplets and compartmentalizing comprises forming the droplets.

50. The method according to claim 32, wherein the droplets are aqueous droplets in an immiscible carrier fluid.

41. A method for screening for a condition in a subject, the method comprising:

obtaining a pool of different nucleic acid from a sample;

compartmentalizing the pool of nucleic acids into compartmentalized portions, the compartmentalized portions comprising, on average, either a first set of binders or a second set of binders, wherein the first and second sets comprise different detectable labels and the first and second sets bind to different nucleic acids in the pool;

amplifying only binders in the compartmentalized portions that bound to the nucleic acid;

detecting the labels; and

screening for a condition based upon results of the detecting step.

42. The method according to claim 41, wherein the binders of the first and second sets bind to a plurality of locations on the different nucleic acids.

43. The method according to claim 42, wherein the binders of the first set comprise the same universal primer site and the binders of the second set comprise the same universal primer site, wherein the primer sites of the first and second binders are different.

44. The method according to claim 43, wherein the compartmentalized portions further comprise universal primers that bind the universal priming sites of the binders of the first set and universal primers that bind the universal priming sites of the binders of the second set.

45. The method according to claim 44, wherein amplifying is the polymerase chain reaction.

46. The method according to claim 44, wherein the compartmentalized portions comprise probes that bind the detectable label of the first set of binders and probes that bind the detectable label of the second set of binders.

47. The method according to claim 46, wherein detecting comprises optically detecting the bound probes.

48. The method according to claim 47, wherein determining comprises:

counting a number of compartmentalized portions comprising the first detectable label;

counting a number of compartmentalized portions comprising the second detectable label; and

determining whether a difference exists between the number of compartmentalized portions comprising the first detectable label and the number of compartmentalized portions comprising the second detectable label.